Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications
Hassan Awada, Bicky Thapa, Valeria Visconte
Cells (2020) Vol. 9, Iss. 11, pp. 2512-2512
Open Access | Times Cited: 18

Showing 18 citing articles:

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
Jason Gotlib, Andreas Reiter, Deepti Radia, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2192-2199
Open Access | Times Cited: 105
JAK-STAT in Early Hematopoiesis and Leukemia
Eirini S. Fasouli, Eleni Katsantoni
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 57
ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome
Robert R. West, Katherine R. Calvo, Lisa J. Embree, et al.
Blood Advances (2021) Vol. 6, Iss. 3, pp. 793-807
Open Access | Times Cited: 38
U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review)
Qing Nian, Yihui Li, Jingwei Li, et al.
Oncology Reports (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 7
Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
Camilla Bertuzzo Veiga, Erin Lawrence, Andrew Murphy, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1968-1968
Open Access | Times Cited: 15
Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatment
Andrea Pellagatti, Jacqueline Boultwood
Advances in Biological Regulation (2022) Vol. 87, pp. 100920-100920
Open Access | Times Cited: 9
The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
Christina‐Nefeli Kontandreopoulou, Konstantinos Kalopisis, Nora‐Athina Viniou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Deregulation of Autophagy and Apoptosis in Patients with Myelodysplastic Syndromes: Implications for Disease Development and Progression
Georgia Tsekoura, Andreas Agathangelidis, Christina‐Nefeli Kontandreopoulou, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 4135-4150
Open Access | Times Cited: 3
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
Diletta Fontana, Carlo Gambacorti‐Passerini, Rocco Piazza
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 7
Spontaneous Splenic Rupture in a Patient with Myelodysplastic Syndrome
Manuel Flores Sáenz
Revista de la Facultad de Medicina de la Universidad de lberoamérica (2024) Vol. 1, Iss. 2, pp. 31-38
Open Access
Recurrent Cytogenetic Abnormalities Reveal Alterations that Promote Progression and Transformation in Myelodysplastic Syndrome
Rolando García, Tasnim Alkayyali, Leyre Gómez, et al.
Cancer Genetics (2024) Vol. 288-289, pp. 92-105
Closed Access
Predictive and prognostic value of gene mutations in myelodysplastic syndrome treated with hypomethylating agents: a meta-analysis
Chaolu Hu, Xiaoqin Wang
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 10, pp. 2336-2351
Closed Access | Times Cited: 1
Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications
Aliaa Arina Rosli, Adam Azlan, Yaashini Rajasegaran, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 4, pp. 1137-1159
Closed Access | Times Cited: 1
Genomic Data Heterogeneity across Molecular Diagnostic Laboratories
Jay Patel, Harry P. Erba, Michael R. Savona, et al.
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 8, pp. 611-618
Open Access
Prognostic Indicators in MDS and CMML
Harinder Gill, Yammy Yung, Cherry Chu, et al.
(2023), pp. 421-435
Closed Access
Comparative Characteristics of Cytogenetic Abnormalities in Different Types of Myelodysplastic Syndromes
Svitlana Andreieva, Kateryna Korets, I. M. Skorohod, et al.
Cytology and Genetics (2022) Vol. 56, Iss. 5, pp. 423-430
Closed Access
Desarrollo y caracterización de un modelo de ratón doble mutante en U2af1 y Tet2 para el estudio de los Síndromes Mielodisplásicos.
Cristina Martínez Valiente
(2022)
Open Access
Different Gene Sets Are Associated With Azacitidine Response In Vitro Versus in Myelodysplastic Syndrome Patients
Marguerite-Marie Le Pannérer, Jeannine Diesch, Raquel Casquero, et al.
HemaSphere (2022) Vol. 6, Iss. 11, pp. e792-e792
Open Access
Page 1

Scroll to top